Novazyme: Getting the translation right

The point of doing targeted therapy is that it generally requires a smaller amount of medication compared to systemic therapy, which relies on diffusion of drug to the site of action. Novazyme Inc. is trying to address the lysosomal storage diseases by using its glycobiology technology to target needed enzymes to their sites of action. By targeting the products, Novazyme hopes to reduce the

Read the full 642 word article

How to gain access

Continue reading with a
two-week free trial.